Jan 26, 2026
Most ViewedJointCaps
The product category "" or "Joint Cap" sits within a crowded over‑the‑counter joint supplement market where formulations mix established nutrients (glucosamine, chondroitin, collagen) with botanicals ...
Regulatory oversight
The ongoing risk of regulatory oversight despite the favorable September court outcome, with potential for renewed policy or competitive pressures to dent sentiment.
Fact-Checks
6 resultsJan 24, 2026
Most ViewedElon Musk Memory help Help
, the brain‑computer interface company founded and funded by , frames as a long‑term ambition built atop initial therapeutic goals like treating paralysis and blindness . Reporting shows early human i...
Jan 7, 2026
Most ViewedWhat are the key safety and efficacy findings from Neuralink’s human trials so far?
Neuralink began first-in-human, early-feasibility trials in 2024 after FDA clearance and publicly announced its first implant in late January 2024, reporting users can move cursors, play games and ope...
Jan 26, 2026
Historical trends for Alphabet stock around late September 2025
’s stock experienced a pronounced rally in , with a material acceleration around mid-to-late month tied to a favorable antitrust court ruling and positive AI-related product and earnings momentum, con...
Jan 10, 2026
Have regulators or consumer agencies issued warnings about Gelatide?
There is no evidence in the provided reporting that regulators or consumer agencies have issued warnings specifically about a product or ingredient named "Gelatide"; none of the sources reference "Gel...
Jan 9, 2026
List drugs and vaccines for which raw patient datasets have not been released
Independent researchers and public-health advocates have repeatedly flagged that raw, participant‑level datasets from several high‑profile COVID‑19 vaccine trials have not been made publicly available...